Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

CNBG Given Go-Ahead to Test HFMD Vaccine

publication date: Dec 27, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China National Biotech Group Co. Ltd. received approval from the SFDA to conduct clinical trials of a vaccine for hand, foot and mouth disease. HFMD, which is caused by enterovirus 71 (EV71), is a recurrent problem in China, mainly affecting children under the age of five. An outbreak of the disease is currently plaguing South Korea. More details....



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors